114 related articles for article (PubMed ID: 23505906)
1. Bortezomib modulates regulatory T cell subpopulations in the process of acute graft-versus-host disease.
Weng J; Lai P; Lv M; Lin S; Ling W; Geng S; Luo C; Liu X; Du X
Clin Lab; 2013; 59(1-2):51-8. PubMed ID: 23505906
[TBL] [Abstract][Full Text] [Related]
2. The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation.
Caballero-Velázquez T; Sánchez-Abarca LI; Gutierrez-Cosio S; Blanco B; Calderon C; Herrero C; Carrancio S; Serrano C; del Cañizo C; San Miguel JF; Pérez-Simón JA
Haematologica; 2012 Sep; 97(9):1329-37. PubMed ID: 22532520
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
[TBL] [Abstract][Full Text] [Related]
4. IL-1β and TLR4 signaling are involved in the aggravated murine acute graft-versus-host disease caused by delayed bortezomib administration.
Liang Y; Ma S; Zhang Y; Wang Y; Cheng Q; Wu Y; Jin Y; Zheng D; Wu D; Liu H
J Immunol; 2014 Feb; 192(3):1277-85. PubMed ID: 24363427
[TBL] [Abstract][Full Text] [Related]
5. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
6. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.
Sun K; Welniak LA; Panoskaltsis-Mortari A; O'Shaughnessy MJ; Liu H; Barao I; Riordan W; Sitcheran R; Wysocki C; Serody JS; Blazar BR; Sayers TJ; Murphy WJ
Proc Natl Acad Sci U S A; 2004 May; 101(21):8120-5. PubMed ID: 15148407
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib attenuates acute graft-vs.-host disease through interfering with host immature dendritic cells.
Tao Y; Zhang W; Fang Y; Yang D; Wang L; Zhou H; Wang J
Exp Hematol; 2011 Jun; 39(6):710-20. PubMed ID: 21392555
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Yao Y; Wang L; Zhou J; Zhang X
J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
[TBL] [Abstract][Full Text] [Related]
10. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
11. [Effect of bortezomib on acute graft-versus-host disease in mice model and its mechanism].
Li ZY; Wu SH; Xu KL; Lu QX; Pan XY; Sun HY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):399-403. PubMed ID: 19951534
[TBL] [Abstract][Full Text] [Related]
12. [Prophylaxis of graft-versus-host disease in mice by chemical modification of graft and OX40-OX40L costimulatory pathway.].
Huang YH; Feng SR; DU B; Xu KL; Pan XY
Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):735-40. PubMed ID: 20137307
[TBL] [Abstract][Full Text] [Related]
13. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
Front Immunol; 2021; 12():647894. PubMed ID: 34262560
[TBL] [Abstract][Full Text] [Related]
14. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
[TBL] [Abstract][Full Text] [Related]
15. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
16. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
17. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels.
Pai CC; Hsiao HH; Sun K; Chen M; Hagino T; Tellez J; Mall C; Blazar BR; Monjazeb A; Abedi M; Murphy WJ
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1899-904. PubMed ID: 25064746
[TBL] [Abstract][Full Text] [Related]
19. [The Effect of γ-secretase Inhibitor Combined with BMSC on the aGVHD in Mice Model].
Wang Y; Li BB; Teng QL; Sun ZG; Liu S; Li CP; Ma H; Guo DM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):937-943. PubMed ID: 34105497
[TBL] [Abstract][Full Text] [Related]
20. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
Wang CL; Xu KL; Pan XY; Du B
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
